Delivery Order SPE2DB22D6029-SPE2DB25FLVSE
- Not listed
- The Defense Logistics Agency awarded a $14,216.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of AVYCAZ 2.5 gram vials, a critical antibiotic pharmaceutical product. The contract was competitively awarded without set-aside designations on July 16, 2025, with an ultimate completion date of July 17, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $49,153.84 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565680281 AVYCAZ 2.5 gram vials, with a period of performance through September 5, 2024. This order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to support...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at thirty thousand six hundred nineteen dollars and thirty-four cents ($30,619.34) to Amerisourcebergen Drug Corporation for 2.5 gram vials of the antibiotic drug AVYCAZ. Place of performance will be Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The single delivery order is for a one day period of performance spanning August 14 to August 15, 2023. No subcontractors or set...
- The Defense Logistics Agency (DLA) awarded a $5,619.47 delivery order to AmerisourceBergen Drug Corp for AKOVAZ 50 mg/mL vials, with performance in Conshohocken, Pennsylvania and completion by September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. As a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $14,731.84 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award (Contract No. 4568975942) represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The contract will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $56,449.48 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on August 27, 2025, by the Defense Logistics Agency Medical Supply Chain to supply Vancomycin 1 GM vials. The contract, valued at $2,781.84 with a firm fixed price structure, has an ultimate completion date of August 28, 2025, and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate office. This delivery order represents a non-set-aside competitive award and is a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,168.96 delivery order for AREXVY vial kits under contract 4568853131 on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement to support federal medical supply requirements. The contract will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,880.46 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract—without set-aside designation—represents a child order under the company's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,674.77 to AmerisourceBergen Drug Corp on August 18, 2025, with completion anticipated by August 19, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVSEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,360.48 to AmerisourceBergen Drug Corp for the supply of AVYCAZ 2.5 gram vials, an antibiotic medication used to treat serious bacterial infections. This firm fixed-price contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competed delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This award is a child contract under AmerisourceBergen's $999,999,999.00 DLA Troop Support Medical IDC (SPE2DX) running through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a critical vendor for medical procurement, particularly for specialty pharmaceutical products supporting military and veteran healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 8/12/25 |